Global Robotics Institute, Florida Hospital Celebration Health Department of Urology, University of Central Florida College of Medicine, Celebration, FL, USA.
Albert Einstein Jewish Hospital, Sao Paulo, Brazil Department of Urology, University of Caracas, Venezuela Department of Urology, Korea University, South Korea.
What's known on the subject? and What does the study add? We have earlier proposed 'pentafecta' as an ideal outcome assessment tool after robotic prostatectomy instead of the classically used 'tritecta'. This was done to meet the demands and expectations of the prostate cancer patients from minimally-invasive surgical techniques. This article reviews each of the five arms of 'pentafecta' outcomes after robotic prostatectomy performed in high volume centres. Historically, the ideal outcome of radical prostatectomy (RP) has been measured by achievement of the so-called 'trifecta', or the concurrent attainment of continence and potency with no evidence of biochemical recurrence. However, in the PSA era, younger and healthier men are more frequently diagnosed with prostate cancer. Such patients have higher expectations from the advanced minimally invasive surgical technologies. Mere trifecta is no longer an ideal outcome measure to meet the demands of such patients. Keeping the limitations of trifecta in mind, we have earlier proposed a new method of outcomes analysis, called the 'pentafecta', which adds early complications and positive surgical margins (PSMs) to trifecta. We performed a Medline search for articles reporting the complications, PSM rates, continence, potency and biochemical recurrence after robot-assisted RP. Related articles were selected and individual outcomes were reviewed.
Written by:
Patel VR, Abdul-Muhsin HM, Schatloff O, Coelho RF, Valero R, Ko YH, Sivaraman A, Palmer KJ, Chauhan S. Are you the author?
Reference: BJU Int. 2011 Sep;108(6):1007-17.
doi: 10.1111/j.1464-410X.2011.10521.x
PubMed Abstract
PMID: 21917104
UroToday.com Prostate Cancer Section
